NCT00061867 Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE1
NCT00061347 Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment Status COMPLETED Phase PHASE1
NCT00061126 ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body Status COMPLETED Phase PHASE2
NCT00060476 Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201) Status COMPLETED Phase PHASE3
NCT00060437 Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate Cancer Status COMPLETED Phase PHASE2
NCT00060398 Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer Status COMPLETED Phase PHASE3
NCT00060086 Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer Status COMPLETED Phase NA
NCT00059943 Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer Status COMPLETED Phase PHASE2
NCT00059631 Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone Status COMPLETED Phase PHASE1
NCT00058539 Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT00058266 Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy Status TERMINATED Phase PHASE2
NCT00058188 Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation Status TERMINATED Phase PHASE3
NCT00057759 Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer Status COMPLETED Phase NA
NCT00055731 Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse Status COMPLETED Phase PHASE3
NCT00054977 Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00054574 Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE2
NCT00054522 Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy Status COMPLETED Phase PHASE2
NCT00054106 Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE1
NCT00052845 Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Status COMPLETED Phase PHASE2